|
Name |
3-Methoxy-2-naphthol
|
Molecular Formula | C11H10O2 | |
IUPAC Name* |
3-methoxynaphthalen-2-ol
|
|
SMILES |
COC1=CC2=CC=CC=C2C=C1O
|
|
InChI |
InChI=1S/C11H10O2/c1-13-11-7-9-5-3-2-4-8(9)6-10(11)12/h2-7,12H,1H3
|
|
InChIKey |
SJTNTIRIRIPZDV-UHFFFAOYSA-N
|
|
Synonyms |
3-Methoxy-2-naphthol; 18515-11-2; 3-methoxynaphthalen-2-ol; 2-Naphthalenol, 3-methoxy-; 2-Hydroxy-3-methoxynaphthalene; 3-METHOXY-2-NAPHTHOL 97; 2-Naphthol, 3-methoxy-; 2-Methoxy-3-naphthol; 3-methoxy-2-naphthalenol; 3-Methoxy-2-naphthol #; 3-methoxy-naphthalen-2-ol; 3-Methoxy-2-naphthol, 97%; SCHEMBL6232041; BDBM36296; DTXSID40171723; ZINC402384; MFCD00029345; AKOS009143252; DB-128412; CS-0044849; D97763; J-011871
|
|
CAS | 18515-11-2 | |
PubChem CID | 599943 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 174.2 | ALogp: | 2.8 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 29.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 13 | QED Weighted: | 0.718 |
Caco-2 Permeability: | -4.47 | MDCK Permeability: | 0.00002190 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.032 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.079 |
30% Bioavailability (F30%): | 0.394 |
Blood-Brain-Barrier Penetration (BBB): | 0.374 | Plasma Protein Binding (PPB): | 95.62% |
Volume Distribution (VD): | 0.886 | Fu: | 3.73% |
CYP1A2-inhibitor: | 0.986 | CYP1A2-substrate: | 0.935 |
CYP2C19-inhibitor: | 0.713 | CYP2C19-substrate: | 0.345 |
CYP2C9-inhibitor: | 0.321 | CYP2C9-substrate: | 0.876 |
CYP2D6-inhibitor: | 0.684 | CYP2D6-substrate: | 0.902 |
CYP3A4-inhibitor: | 0.208 | CYP3A4-substrate: | 0.299 |
Clearance (CL): | 13.238 | Half-life (T1/2): | 0.785 |
hERG Blockers: | 0.052 | Human Hepatotoxicity (H-HT): | 0.095 |
Drug-inuced Liver Injury (DILI): | 0.685 | AMES Toxicity: | 0.747 |
Rat Oral Acute Toxicity: | 0.075 | Maximum Recommended Daily Dose: | 0.671 |
Skin Sensitization: | 0.933 | Carcinogencity: | 0.784 |
Eye Corrosion: | 0.654 | Eye Irritation: | 0.99 |
Respiratory Toxicity: | 0.775 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002077 | 0.542 | D0E9CD | 0.396 | ||||
ENC000033 | 0.512 | D0DJ1B | 0.377 | ||||
ENC001537 | 0.490 | D05CKR | 0.349 | ||||
ENC000169 | 0.468 | D02NTO | 0.333 | ||||
ENC000714 | 0.440 | D0L5PO | 0.328 | ||||
ENC001512 | 0.426 | D04JEE | 0.319 | ||||
ENC000172 | 0.422 | D00CSQ | 0.313 | ||||
ENC002427 | 0.396 | D07MGA | 0.307 | ||||
ENC000027 | 0.396 | D09JUG | 0.306 | ||||
ENC000068 | 0.396 | D07HBX | 0.306 |